|
OXA1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.52499999587164E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.13260000009919E-07 |
| Normal-vs-Stage2 |
9.758500E-03 |
| Normal-vs-Stage3 |
3.676800E-03 |
| Normal-vs-Stage4 |
6.393600E-02 |
| Stage1-vs-Stage2 |
6.716800E-01 |
| Stage1-vs-Stage3 |
6.290800E-01 |
| Stage1-vs-Stage4 |
5.377200E-01 |
| Stage2-vs-Stage3 |
9.975600E-01 |
| Stage2-vs-Stage4 |
6.963600E-01 |
| Stage3-vs-Stage4 |
6.858400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15080000032231E-07 |
| Normal-vs-AfricanAmerican |
1.54862999999228E-05 |
| Normal-vs-Asian |
1.013820E-01 |
| Caucasian-vs-AfricanAmerican |
8.187600E-01 |
| Caucasian-vs-Asian |
7.584200E-01 |
| AfricanAmerican-vs-Asian |
7.970200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.64710000772584E-09 |
| Normal-vs-Female |
3.421400E-03 |
| Male-vs-Female |
5.072400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.061200E-03 |
| Normal-vs-Extreme_Weight |
3.78769999997974E-06 |
| Normal-vs-Obese |
4.2989999999965E-05 |
| Normal-vs-Extreme_Obese |
4.653900E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.807600E-01 |
| Normal_Weight-vs-Obese |
4.837200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.604000E-01 |
| Extreme_Weight-vs-Obese |
5.502600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.635600E-01 |
| Obese-vs-Extreme_Obese |
8.068600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.668020E-02 |
| Normal-vs-Age(41-60Yrs) |
7.32720000229392E-08 |
| Normal-vs-Age(61-80Yrs) |
3.84300000000337E-06 |
| Normal-vs-Age(81-100Yrs) |
5.250400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.716200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.470600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.001000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.961020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.786400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.975000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.57019999727603E-08 |
| Normal-VS-Type2 PRCC |
1.84260000002379E-06 |
| Normal-VS-KIRP CIMP |
6.013000E-01 |
| Normal-VS-Unclassified PRCC |
6.360100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.309600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.960700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.643800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.299720E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.799600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.428100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.036300E-04 |
| Normal-vs-N1 |
2.194200E-02 |
| Normal-vs-N2 |
3.295800E-01 |
| N0-vs-N1 |
5.838000E-01 |
| N0-vs-N2 |
1.132760E-01 |
| N1-vs-N2 |
1.479790E-01 |
|
|
